Therefore, much effort has been directed towards developing HDAC inhibitors as an HD therapeutic [17] and initial genetic studies performed in flies and worms have confirmed that these may have a significant potential [14],[18],[19]. The gene discussed is HDAC9; the disease is Huntington disease.